Gastric Cancer
Copyright ©The Author(s) 2002.
World J Gastroenterol. Jun 15, 2002; 8(3): 455-458
Published online Jun 15, 2002. doi: 10.3748/wjg.v8.i3.455
Table 1 The effect of rhEGF i.p. on the growth of MKN-28 tumor in nude mice
GroupDosagenBody mass/g
Tumor mass -x±s/gInhibitary rate/%P value
BeginningEnd
NS0.2 mL1617.622.61.97 ± 0.94————
MMC2 μg·kg-1817.820.00.47 ± 0.6176.2< 0.05
RhEGF15 μg·kg-1817.422.01.75 ± 0.8111.1< 0.05
RhEGF30 μg·kg-1817.923.81.91 ± 0.983.0< 0.05
RhEGF60 μg·kg-1817.922.92.08 ± 1.56-5.3< 0.05
Table 2 The effect of rhEGF i.p. on the growth of SGC-7901 tumor in nude mice
GroupDosagenBody mass/g
Tumor mass -x±s/gInhibitary rate/%P value
BeginningEnd
NS0.2 mL1614.425.21.07 ± 0.60——
MMC2 μg·kg-1815.221.70.66 ± 0.2938.6< 0.05
RhEGF15 μg·kg-1815.925.31.53 ± 0.29-43.8< 0.05
RhEGF30 μg·kg-1814.123.81.07 ± 0.63-0.7< 0.05
RhEGF60 μg·kg-1813.423.91.20 ± 0.47-12.5< 0.05
Table 3 The effect of rhEGF i.p. on the growth of MKN-45 tumor in nude mice
GroupDosagenBody mass/g
Tumor mass -x±s/gInhibitary rate/%P value
BeginningEnd
NS0.2 mL2016.119.81.82 ± 0.95——
MMC2 μg·kg-11016.219.71.07 ± 0.4241.1< 0.05
RhEGF15 μg·kg-11016.020.31.92 ± 1.04-5.5< 0.05
RhEGF30 μg·kg-11016.519.81.29 ± 0.838.0< 0.05
RhEGF60 μg·kg-1816.120.41.77 ± 1.043.1< 0.05